卡培他滨
Capecitabine;Capcitabine;Pentyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydr;5'-DEOXY-5-FLUOROCYTISINE;5'-DEOXY-5-FLUORO-N-[(PENTYLOXY)CARBONYL]CYTIDINE;RO-9-1978;pentyl [1-(3,4-dihydroxy-5-methyl-oxolan-2-yl)-5-fluoro-2-oxo-pyrimidin-4-yl]aminoformate;XELODA;CAPECITABINE USP32;Pentyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate; 000;5'-Deoxy-5-fluoro-N4-[(pentyloxy)carbonyl]cytidine;Capecitibine;Capecytabine;Captabin;Cpecitabine;Ro 09-1978;5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine;Chi Pei he;[ "" ];Capiibine;N(4)-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine;5'-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)cytidine;R340;Cytidine, 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-;Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate;Pentyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyr;CAPECITABINE;CAPECITABINE [EP MONOGRAPH];pentyl 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-ylcarbamate;Capecitabine, European Pharmacopoeia (EP) Reference Standard;NCGC00164569-05;Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate;NCGC00164569-02;5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine;AKOS015920130;NCGC00164569-01;AB01274776-01;CAPECITABINE [VANDF];Capecitabine Tablets, 500 mg;CS-0768;pentyl N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl}carbamate;RG-340;PENTYL 1-(5-DEOXY-.BETA.-D-RIBOFURANOSYL)-5-FLUORO-1,2-DIHYDRO-2-OXO-4-PYRIMIDINECARBAMATE;CAPECITABINE [EMA EPAR];Capecitabine, United States Pharmacopeia (USP) Reference Standard;5-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine;Q-200788;Capecitabine, >=98% (HPLC);CAPECITABINE [ORANGE BOOK];D01223;NSC712807;DTXCID1026451;6804DJ8Z9U;CAPECITABINE [USP IMPURITY];Xeloda;SMR002530052;Ro-09-1978-000;MLS003915642;Xabine;R-340;Capecitabine Tablets, 150 mg;Xelox component capecitabine;CAPECITABINE (USP-RS);Ro 09-1978/000;BC164277;capecitabinum;CAPECITABINE (EP MONOGRAPH);Capecitabine [USAN];CAPECITABINE [INN];SR-01000931255;5-Deoxy-5-fluoro-N4-[(pentyloxy)carbonyl]cytidine;AB01274776_04;BCP9000483;capecitabina;154361-50-9;NSC 759853;Capecitabine [USAN:USP:INN:BAN];5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine;Capecitabin;J-700154;GTPL6799;Capecitabine (JAN/USP/INN);HY-B0016;CAPECITABINE [MI];Capecitabine 500mg;5'-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)-cytidine;CAPECITABINE [WHO-DD];DTXSID3046451;CHEBI:31348;HSDB 7656;BS-1000;CAPECITABINE (USP MONOGRAPH);(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester;3-(2-HYDROXYETHYL)THIAZOLIUMBROMIDE;Capecitabine (USAN:USP:INN:BAN);DB01101;CAPECITABINE [HSDB];CARBAMIC ACI...